Delivery Order SPE2DX22D0010-SPE2D825FHC31
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,289.80 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $5,573.88. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order is issued as a child contract under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Concerta ER Tablets 18mg, with a ceiling value of $1,588.38. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100 count) with a ceiling value of $5,428.87. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The product will be performed...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,413.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,287,331 units of the pharmaceutical product Concerta ER 36 mg tablets. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a $21,395.38 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This award was competitively awarded...
- This delivery order, awarded July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. The contract carries a firm fixed price ceiling value of $37,627.80 with an ultimate completion date of July 24, 2025. The award represents a competitively awarded, non-set-aside contract and is performed from the vendor's corporate...
- This delivery order, awarded July 24, 2025, represents a competitive, non-set-aside contract awarded to AmerisourceBergen Drug Corp for the supply of Concerta ER (extended-release) tablets at 36 mg strength. The contract, valued at $32,045.46 with a completion date of July 25, 2025, is funded by the Defense Department's Medical Supply Chain and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The firm fixed-price delivery order structure reflects...
- The Defense Logistics Agency awarded a $3,301.25 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, with an ultimate completion date of July 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHC31Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,459.67 on July 22, 2025, for the supply of Concerta ER Tabs 36mg. This firm fixed price contract, which is scheduled for completion by July 23, 2025, represents a competitive award with no set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications and medical supplies to support military healthcare programs. The current delivery order for Concerta ER Tabs 36mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder, exemplifies the contractor's role in fulfilling specialized pharmaceutical requirements for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/22/25 |